FAP immunosuppressive CAR-DC

BIOLOGICAL2 trials

Sponsors

Second Affiliated Hospital, School of Medicine, Zhejiang University

Conditions

Dilated Cardiomyopathy (DCM)Heart Failure

Phase 1

Safety and Efficacy of FAP iCDC in End-stage Dilated Cardiomyopathy

RecruitingNCT06902896

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityDilated Cardiomyopathy (DCM), Heart Failure

Start: 2025-04-22End: 2028-12-31Target: 43Updated: 2026-07-14

Safety and Efficacy of Second Infusion of FAP iCDC in End-stage Dilated Cardiomyopathy

RecruitingNCT07516288

Second Affiliated Hospital, School of Medicine, Zhejiang UniversityDilated Cardiomyopathy (DCM), Heart Failure

Start: 2026-05-11End: 2027-12-31Target: 5Updated: 2026-07-02